Sobol, Robert E., Scanlon, Kevin J., Nestaas, Eirik (Eds.)
Softcover reprint of the original 1st ed. 1998, XII, 242 p.
Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
This book is a collection of preclinical and clinical reports on the application of gene therapy to human disease. The two methods available for delivering therapeutic genes to diseased cells, viral and non-viral vector systems, are detailed and characterized. Several reports describe both approaches currently used in gene therapy: the introduction of a wild-type gene to restore normal gene function in diseased cells, and the use of antisense molecules to hinder abnormal gene expression. Clinical studies detail several different strategies for the treatment of cancer and cardiovascular diseases, using genetic material as therapeutic agents. The regulatory issues governing the use of gene therapy in Europe and the United States are also presented. This book highlights the range of applications and demonstrates the rapid progress being made in the field of gene therapy.
Human Gene Therapy: Future Prospects; Approaches to the Gene Therapy of Cancer Using Replication-Adenoviruses; Synthetic Gene Delivery; Tumor Suppressor Genes; Oligonucleotide Therapeutics for Human Leukemia; Ribozymes as Biotherapeutic Tools for the Modulation of Gene; Cardiovascular Gene Therapy; Protection of Hematopoietic Progenitor Cells from Chemotherapy Toxicity by Transfer of Drug Resistance Genes; Pro-drug Gene Therapy for Prostate Cancer; Hematopoietic Ex Vivo Gene Transfer; Immunological Approaches for Gene Therapy of Cancer; Gene Therapy Regulatory Issues